search
Back to results

Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens Users

Primary Purpose

Astigmatism

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
Senofilcon A Toric (AOfA)
Etafilcon A Toric (1DAMfA)
Sponsored by
Johnson & Johnson Vision Care, Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Astigmatism

Eligibility Criteria

16 Years - 60 Years (Child, Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

Subjects must satisfy the following conditions prior to inclusion in the study:

  1. One of the following:

    1. Spherical contact lens user (minimum of 2 months wear, four days a week, 8 hours a day)
    2. Contact Lens drop-out (no contact lens wear in the last 6 months but wearing glasses at least four days a week,8 hours a day)
    3. Neophyte (no habitual contact lens wear except for trial fits up to 1 week, but wearing glasses at least four days a week,8 hours a day For patients not currently wearing lenses, patient should have expressed a desire to try lenses.
  2. Between 16 and 60 years of age.
  3. Have signed an informed consent form (documented by the investigator in the Case Report Form [CRF]).
  4. Distance requirement in the range of +4.00D to -9.00D (i.e. -10.00D refractive)
  5. Refractive astigmatism between -0.75D and -3.00D in both eyes.
  6. Have best corrected VA of 6/9 (20/30) or better in each eye.
  7. Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having:

    1. No amblyopia.
    2. No evidence of lid abnormality or infection.
    3. No conjunctival abnormality or infection.
    4. No clinically significant slit lamp findings (i.e. stromal haze, staining, scarring, vascularisation, infiltrates or abnormal opacities).
    5. No other active ocular disease.
  8. Presbyopes may be included (no monovision, no spectacles over contact lenses or bifocal glasses only)

Exclusion Criteria:

Any of the following will render a subject ineligible for inclusion:

  1. Requires concurrent ocular medication.
  2. Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperaemia, limbal hyperaemia, or any other abnormality of the cornea that would contraindicate contact lens wear.
  3. Corneal staining Grade 3 in more than two regions.
  4. Extended wear in the last 3 months.
  5. Has had any anterior ocular surgery. Has had any other ocular surgery or injury within 8 weeks immediately prior to enrollment for this study.
  6. Abnormal lachrymal secretions.
  7. Pre-existing ocular irritation that would preclude contact lens fitting.
  8. Keratoconus or other corneal irregularity.
  9. Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear.
  10. Has diabetes.
  11. Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV).
  12. Pregnancy, lactating, or planning a pregnancy at the time of enrollment.
  13. Participation in any concurrent clinical trial or in last 60 days.

Sites / Locations

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Other

Other

Other

Arm Label

Spherical contact lens users

Contact lens drop-outs

Habitual Correction with Spectacles (Neophytes)

Arm Description

Habitual spherical contact lens (non-toric lens) users tried one of two toric lenses in a daily wear modality.

Habitual spectacle users (for vision correction) who have failed contact lens fit and wear, tried one of two toric lenses in a daily wear modality.

Habitual spectacle lens wearers (for vision correction) who have never used or been fitted with contact lenses tried one of two toric lenses in a daily wear modality.

Outcomes

Primary Outcome Measures

Overall Success in Fitting With a Toric Contact Lens
Percent of subjects with success with toric lens fitting defined as meeting all of the following pre-determined criteria: 1) acceptable fit, 2) orientation stability less than or equal to 20 degree rotation, 3) binocular visual acuity (VA) within one line of spectacle VA, 4) Good, very good, or excellent overall quality of Vision, and 5) good, very, good, or excellent overall lens comfort. There was not an inferential statistical analysis conducted on this outcome. Comparison was made through the use of 95% CI's for the proportions. Therefore no statistical analysis section is included for this primary outcome.
Distance Visual Acuity
Measured monocularly (each eye separately) in Snellen converted to logMAR units. The logMAR scale has a range of -0.30 to 1.00. A value of 0 or less would not require distance vision correction and a value of 0 or greater may require distance vision correction.
Distance Visual Acuity (VA)
Visual Acuity is measured monocularly (each eye separately) in Snellen, the converted to logMAR units. The logMAR scale has a range of -0.30 to 1.00. A value of 0 or less would not require distance vision correction and a value of 0 or greater may require distance vision correction.

Secondary Outcome Measures

Full Information

First Posted
August 11, 2010
Last Updated
June 18, 2018
Sponsor
Johnson & Johnson Vision Care, Inc.
Collaborators
Visioncare Research Ltd.
search

1. Study Identification

Unique Protocol Identification Number
NCT01180998
Brief Title
Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens Users
Study Type
Interventional

2. Study Status

Record Verification Date
June 2017
Overall Recruitment Status
Completed
Study Start Date
June 1, 2010 (Actual)
Primary Completion Date
October 1, 2010 (Actual)
Study Completion Date
October 1, 2010 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Johnson & Johnson Vision Care, Inc.
Collaborators
Visioncare Research Ltd.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to evaluate the clinical performance, defined as successful fit, of two toric contact lenses (one daily disposable and the other daily wear reusable contact lens to correct astigmatism) in current spherical soft contact lens wearers, contact lens drop-outs, and non-users of toric contact lenses (neophytes).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Astigmatism

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
200 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Spherical contact lens users
Arm Type
Other
Arm Description
Habitual spherical contact lens (non-toric lens) users tried one of two toric lenses in a daily wear modality.
Arm Title
Contact lens drop-outs
Arm Type
Other
Arm Description
Habitual spectacle users (for vision correction) who have failed contact lens fit and wear, tried one of two toric lenses in a daily wear modality.
Arm Title
Habitual Correction with Spectacles (Neophytes)
Arm Type
Other
Arm Description
Habitual spectacle lens wearers (for vision correction) who have never used or been fitted with contact lenses tried one of two toric lenses in a daily wear modality.
Intervention Type
Device
Intervention Name(s)
Senofilcon A Toric (AOfA)
Intervention Description
Soft toric contact lenses for astigmatism
Intervention Type
Device
Intervention Name(s)
Etafilcon A Toric (1DAMfA)
Intervention Description
Soft toric contact lenses for astigmatism
Primary Outcome Measure Information:
Title
Overall Success in Fitting With a Toric Contact Lens
Description
Percent of subjects with success with toric lens fitting defined as meeting all of the following pre-determined criteria: 1) acceptable fit, 2) orientation stability less than or equal to 20 degree rotation, 3) binocular visual acuity (VA) within one line of spectacle VA, 4) Good, very good, or excellent overall quality of Vision, and 5) good, very, good, or excellent overall lens comfort. There was not an inferential statistical analysis conducted on this outcome. Comparison was made through the use of 95% CI's for the proportions. Therefore no statistical analysis section is included for this primary outcome.
Time Frame
4 weeks
Title
Distance Visual Acuity
Description
Measured monocularly (each eye separately) in Snellen converted to logMAR units. The logMAR scale has a range of -0.30 to 1.00. A value of 0 or less would not require distance vision correction and a value of 0 or greater may require distance vision correction.
Time Frame
after 1 week of toric contact lens wear
Title
Distance Visual Acuity (VA)
Description
Visual Acuity is measured monocularly (each eye separately) in Snellen, the converted to logMAR units. The logMAR scale has a range of -0.30 to 1.00. A value of 0 or less would not require distance vision correction and a value of 0 or greater may require distance vision correction.
Time Frame
after 4 weeks of toric contact lens wear

10. Eligibility

Sex
All
Minimum Age & Unit of Time
16 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Subjects must satisfy the following conditions prior to inclusion in the study: One of the following: Spherical contact lens user (minimum of 2 months wear, four days a week, 8 hours a day) Contact Lens drop-out (no contact lens wear in the last 6 months but wearing glasses at least four days a week,8 hours a day) Neophyte (no habitual contact lens wear except for trial fits up to 1 week, but wearing glasses at least four days a week,8 hours a day For patients not currently wearing lenses, patient should have expressed a desire to try lenses. Between 16 and 60 years of age. Have signed an informed consent form (documented by the investigator in the Case Report Form [CRF]). Distance requirement in the range of +4.00D to -9.00D (i.e. -10.00D refractive) Refractive astigmatism between -0.75D and -3.00D in both eyes. Have best corrected VA of 6/9 (20/30) or better in each eye. Have normal eyes with no evidence of abnormality or disease. For the purpose of this study a normal eye is defined as one having: No amblyopia. No evidence of lid abnormality or infection. No conjunctival abnormality or infection. No clinically significant slit lamp findings (i.e. stromal haze, staining, scarring, vascularisation, infiltrates or abnormal opacities). No other active ocular disease. Presbyopes may be included (no monovision, no spectacles over contact lenses or bifocal glasses only) Exclusion Criteria: Any of the following will render a subject ineligible for inclusion: Requires concurrent ocular medication. Clinically significant (Grade 3 or 4) corneal stromal haze, corneal vascularisation, tarsal abnormalities, bulbar hyperaemia, limbal hyperaemia, or any other abnormality of the cornea that would contraindicate contact lens wear. Corneal staining Grade 3 in more than two regions. Extended wear in the last 3 months. Has had any anterior ocular surgery. Has had any other ocular surgery or injury within 8 weeks immediately prior to enrollment for this study. Abnormal lachrymal secretions. Pre-existing ocular irritation that would preclude contact lens fitting. Keratoconus or other corneal irregularity. Any systemic illness which would contraindicate lens wear or the medical treatment of which would affect vision or successful lens wear. Has diabetes. Infectious disease (e.g., hepatitis, tuberculosis) or an immunosuppressive disease (e.g., HIV). Pregnancy, lactating, or planning a pregnancy at the time of enrollment. Participation in any concurrent clinical trial or in last 60 days.
Facility Information:
City
Reading
State/Province
Berkshire
Country
United Kingdom
City
Marlow
State/Province
Bucks
Country
United Kingdom
City
Broadstone
State/Province
Dorset
Country
United Kingdom
City
Portchester
State/Province
Hampshire
Country
United Kingdom
City
Southsea
State/Province
Hampshire
Country
United Kingdom
City
St. Albans
State/Province
Herts
Country
United Kingdom
City
Shanklin
State/Province
Isle Of Wight
Country
United Kingdom
City
Rawtenstall
State/Province
Lancashire
Country
United Kingdom
City
Hendon
State/Province
London
Country
United Kingdom
City
Pinner
State/Province
Middlesex
Country
United Kingdom
City
Teddington
State/Province
Middlesex
Country
United Kingdom
City
Uxbridge
State/Province
Middlesex
Country
United Kingdom
City
Cardiff
State/Province
South Glamorgan
Country
United Kingdom
City
Croydon
State/Province
Surrey
Country
United Kingdom
City
Coventry
State/Province
West Midlands
Country
United Kingdom
City
Birmingham
Country
United Kingdom
City
Bristol
Country
United Kingdom
City
Sheffield
Country
United Kingdom

12. IPD Sharing Statement

Learn more about this trial

Clinical Evaluation of Two Toric Contact Lenses in Current Non-toric Lens Users

We'll reach out to this number within 24 hrs